Stay updated on MRx0518 and Pembrolizumab Combo in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the MRx0518 and Pembrolizumab Combo in Solid Tumors Clinical Trial page.

Latest updates to the MRx0518 and Pembrolizumab Combo in Solid Tumors Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedRevision: v3.4.2 was added and the prior notice about government funding and operating status (Revision: v3.4.1) was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check21 days agoChange DetectedNotice added about a lapse in government funding and NIH Clinical Center status, with links to cc.nih.gov and opm.gov, and the site revision updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check28 days agoChange DetectedAdded a glossary display and updated QC/version labels to 'Last Update Submitted that Met QC Criteria' with revision v3.4.0; removed the older 'Last Update Submitted that met QC Criteria' phrasing, removed the 'No FEAR Act data' note, and dropped the previous v3.3.4 reference.SummaryDifference0.2%

- Check42 days agoChange DetectedRevision: v3.3.4 is displayed, replacing v3.3.3. There are no visible changes to the study content or core details on the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check63 days agoChange DetectedA dedicated Locations section and listed sites (Kansas, Pennsylvania, Texas, Washington) were added, reorganizing location information for the study.SummaryDifference0.5%

- Check92 days agoChange DetectedPage revision history updated from v3.2.0 to v3.3.2.SummaryDifference0.1%

Stay in the know with updates to MRx0518 and Pembrolizumab Combo in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the MRx0518 and Pembrolizumab Combo in Solid Tumors Clinical Trial page.